Company intelligence / Profile preview

TriApex Laboratories

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

TriApex is an innovative CRO providing nonclinical and clinical research services to pharmaceutical companies globally. It specializes in disease-oriented R&D with expertise in ophthalmology, CNS disorders, metabolic diseases, and cardiovascular disease. The company offers regulatory-compliant data generation from molecular assays to advanced in vivo studies—including work with non-human primates—and has experience supporting CFDA/FDA submissions.

Modalities: Small moleculeBiologicCell therapyMedical device
Industry: Contract Research Organization

Partnerships

Collaborations with top international pharma companies including AstraZeneca and Merck

Beyond the preview

Go deeper on TriApex Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TriApex Laboratories.

Explore the full profile